Century Therapeutics (IPSC) Return on Invested Capital (2024)
Historic Return on Invested Capital for Century Therapeutics (IPSC) over the last 3 years, with Q4 2024 value amounting to 0.78%.
- Century Therapeutics' Return on Invested Capital fell 500.0% to 0.78% in Q4 2024 from the same period last year, while for Dec 2024 it was 0.78%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.81% for FY2024, which is 2100.0% down from last year.
- As of Q4 2024, Century Therapeutics' Return on Invested Capital stood at 0.78%, which was down 500.0% from 0.69% recorded in Q3 2024.
- Century Therapeutics' Return on Invested Capital's 5-year high stood at 0.42% during Q4 2022, with a 5-year trough of 0.81% in Q1 2024.
- For the 3-year period, Century Therapeutics' Return on Invested Capital averaged around 0.63%, with its median value being 0.69% (2024).
- Within the past 5 years, the most significant YoY rise in Century Therapeutics' Return on Invested Capital was -500bps (2024), while the steepest drop was -3700bps (2024).
- Over the past 3 years, Century Therapeutics' Return on Invested Capital (Quarter) stood at 0.42% in 2022, then crashed by -77bps to 0.74% in 2023, then decreased by -7bps to 0.78% in 2024.
- Its Return on Invested Capital was 0.78% in Q4 2024, compared to 0.69% in Q3 2024 and 0.73% in Q2 2024.